Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.13 -0.15 (-3.62%)
At close: Oct 22, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Long-Term Debt Issuances (2020)

Updated

Corbus Pharmaceuticals Holdings (CRBP) recorded Long-Term Debt Issuances of $373,000 in FY2023, down 73.0% from $1.38 million in FY2022.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Long-Term Debt Issuances (2020) Analysis & Trends

Starting with FY2013, Corbus Pharmaceuticals Holdings' Long-Term Debt Issuances history includes 10 years.

  • Annual Long-Term Debt Issuances has a five-year compound annual growth rate of -5.4% (FY2018 to FY2023).
  • The FY2023 figure is the lowest annual Long-Term Debt Issuances since FY2015.
  • Per Business Quant data, CRBP's Long-Term Debt Issuances was $1.38 million in FY2022 (+40.4%), $984,375 in FY2021 (-94.8%), $18.76 million in FY2020 and $963,514 in FY2019 (+96.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Corbus Pharmaceuticals Holdings 50.64 Mn -465.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 909,375.00
API Access

Corbus Pharmaceuticals Holdings Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CRBP&period=max&api_key=YOUR_API_KEY